|
Market Closed -
Other stock markets
|
Pre-market 07:00:25 am | |||
| 258.16 USD | -6.03% |
|
256.64 | -0.59% |
| Dec. 16 | Wall St slips on losses in healthcare stocks, focus on 'distorted' economic data | RE |
| Dec. 16 | Humana reaffirms FY 2025 guidance of $12.26 EPS | RE |
| Capitalization | 31.05B 26.37B 24.67B 23.12B 42.68B 2,823B 46.78B 288B 111B 1,326B 116B 114B 4,807B | P/E ratio 2025 * |
20.5x | P/E ratio 2026 * | 21.6x |
|---|---|---|---|---|---|
| Enterprise value | 38.84B 32.99B 30.86B 28.93B 53.39B 3,531B 58.52B 360B 139B 1,659B 146B 143B 6,013B | EV / Sales 2025 * |
0.3x | EV / Sales 2026 * | 0.27x |
| Free-Float |
60.46% | Yield 2025 * |
1.41% | Yield 2026 * | 1.54% |
Last Transcript: Humana Inc.
| 1 day | -0.59% | ||
| 1 week | +3.10% | ||
| Current month | +5.04% | ||
| 1 month | +8.87% | ||
| 3 months | -5.20% | ||
| 6 months | +9.67% | ||
| Current year | +1.75% |
| 1 week | 254.71 |  | 274.99 |
| 1 month | 221.5 | | 274.99 |
| Current year | 206.87 | | 315.35 |
| 1 year | 206.87 | | 315.35 |
| 3 years | 206.87 | | 541.21 |
| 5 years | 206.87 | | 571.3 |
| 10 years | 150 | | 571.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Rechtin
CEO | Chief Executive Officer | 54 | 2024-06-30 |
Celeste Brown
DFI | Director of Finance/CFO | 48 | 2025-01-10 |
Japan Mehta
CTO | Chief Tech/Sci/R&D Officer | 44 | 2025-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kurt Hilzinger
CHM | Chairman | 64 | 2013-12-31 |
Frank D'Amelio
BRD | Director/Board Member | 67 | 2003-08-31 |
Karen Katz
BRD | Director/Board Member | 68 | 2019-09-22 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 2.3% | 5 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -6.03% | +3.10% | -0.88% | -48.73% | 31.05B | |
| -2.02% | +3.28% | -32.96% | -36.18% | 303B | |
| -2.43% | +6.70% | -5.73% | -29.91% | 78.21B | |
| -0.38% | +5.10% | +1.04% | -15.64% | 73.76B | |
| -3.66% | +2.34% | -34.14% | -52.13% | 19.15B | |
| -3.38% | +2.55% | -45.55% | -51.96% | 8.27B | |
| -0.40% | +4.27% | +78.68% | +71.78% | 4.01B | |
| -1.25% | +5.22% | +74.68% | -18.28% | 2.24B | |
| +0.76% | +1.93% | -15.38% | +149.06% | 1.36B | |
| -2.48% | -7.37% | -26.84% | - | 370M | |
| Average | -0.83% | +2.77% | -0.71% | -3.55% | 52.12B | |
| Weighted average by Cap. | -0.55% | +4.00% | -21.02% | -32.52% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 129B 110B 103B 96.2B 178B 11,744B 195B 1,199B 463B 5,517B 484B 474B 19,998B | 144B 122B 114B 107B 197B 13,049B 216B 1,332B 514B 6,130B 538B 527B 22,220B |
| Net income | 1.51B 1.28B 1.2B 1.12B 2.07B 137B 2.27B 14B 5.4B 64.44B 5.66B 5.54B 234B | 1.45B 1.23B 1.15B 1.08B 1.99B 132B 2.18B 13.45B 5.19B 61.88B 5.43B 5.32B 224B |
| Net Debt | 7.79B 6.62B 6.19B 5.8B 10.71B 708B 11.74B 72.32B 27.9B 333B 29.23B 28.62B 1,206B | 7.66B 6.51B 6.09B 5.71B 10.53B 697B 11.54B 71.12B 27.44B 327B 28.74B 28.15B 1,186B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-16 | 258.16 $ | -6.03% | 3,000,183 |
| 25-12-15 | 274.74 $ | +2.34% | 2,028,861 |
| 25-12-12 | 268.45 $ | +0.74% | 1,130,742 |
| 25-12-11 | 266.49 $ | +3.83% | 1,902,247 |
| 25-12-10 | 256.66 $ | +2.50% | 1,046,980 |
Delayed Quote Nyse, December 16, 2025 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HUM Stock
Select your edition
All financial news and data tailored to specific country editions
